These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36086704)

  • 21. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
    Chawla YK; Kashinath RC; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis.
    Wang J; Zhang Z; Yan X; Li M; Xia J; Liu Y; Chen Y; Jia B; Zhu L; Zhu C; Huang R; Wu C
    Dig Liver Dis; 2019 Aug; 51(8):1172-1178. PubMed ID: 30765220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
    Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
    ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
    Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
    J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing Functional Frailty and Radiographic Sarcopenia as Predictors of Outcomes After Liver Transplant.
    Olson SL; Polineni P; Schwartz WAH; Thuluvath AJ; Duarte-Rojo A; Ladner DP
    Clin Transplant; 2024 Jul; 38(7):e15412. PubMed ID: 39049617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Child-Turcotte-Pugh Score, MELD Score and MELD-Na Score as Predictors of Short-Term Mortality among Patients with End-Stage Liver Disease in Northern India.
    Acharya G; Kaushik RM; Gupta R; Kaushik R
    Inflamm Intest Dis; 2020 Feb; 5(1):1-10. PubMed ID: 32232049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P; Desai N; Alexander J; Singh DP; Sawant P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring sarcopenia on pre-operative CT in older adults undergoing emergency laparotomy: a comparison of three different calculations.
    Simpson G; Manu N; Magee C; Wilson J; Moug S; Vimalachandran D
    Int J Colorectal Dis; 2020 Jun; 35(6):1095-1102. PubMed ID: 32215679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Mortality in Long-Term Follow-Up of Patients with Terminal Alcoholic Cirrhosis: Is It Time to Accept Remodeled Scores?
    Radisavljevic MM; Bjelakovic GB; Nagorni AV; Stojanovic MP; Radojkovicn MD; Jovic JZ; Ignjatovic AM; Radisavljevic MM; Simonovic MM
    Med Princ Pract; 2017; 26(2):169-175. PubMed ID: 27676412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The prognostic value of end-stage liver disease model in liver cirrhosis].
    Zhang JY; Zhang FK; Wang BE; Jia JD; Zhang ST
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MELD-Na: effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy.
    Wang J; Wang AJ; Li BM; Liu ZJ; Chen L; Wang H; Shi F; Zhu X
    J Clin Gastroenterol; 2014; 48(10):870-7. PubMed ID: 24296420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
    Corneille MG; Nicholson S; Richa J; Son C; Michalek J; Wolf SE; Stewart R
    J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt.
    March C; Thormann M; Geipel S; Sowa JP; Barajas Ordonez F; Pech M; Omari J; Lemmer P
    Sci Rep; 2023 Oct; 13(1):17092. PubMed ID: 37816875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
    Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
    J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different scoring systems to predict 6-week mortality in cirrhosis patients with acute variceal bleeding: a retrospective analysis of 202 patients.
    Wang F; Cui S; Wang F; Li F; Tang F; Zhang X; Gao Y; Lv H
    Scand J Gastroenterol; 2018; 53(7):885-890. PubMed ID: 29911438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Utility of the Platelet-Albumin-Bilirubin Score as a Non-invasive Predictor of Esophageal Varices and Variceal Hemorrhage in Patients With Liver Cirrhosis Compared to Child-Turcotte-Pugh and Model of End-Stage Liver Disease-Sodium Scores.
    Malik A; Asif M; Ud Din R; Khan A; Siddique M; Noor F; Mansoor H; Habib A
    Cureus; 2024 Jun; 16(6):e62577. PubMed ID: 39027759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver.
    Gupta S; Chawla Y; Kaur J; Saxena R; Duseja A; Dhiman RK; Choudhary NS
    Trop Gastroenterol; 2012; 33(2):129-34. PubMed ID: 23025060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
    Hassan EA; Abd El-Rehim AS
    Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varices.
    Nishikawa H; Yuri Y; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Hasegawa K; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Takata R; Iijima H; Nishiguchi S
    Medicine (Baltimore); 2017 May; 96(19):e6868. PubMed ID: 28489785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.